WHO ICTRP trial
High Flow Nasal Oxygen during Endobronchial Ultrasound to prevent low oxygen…
ACTRN12616001691437 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12616001691437 |
|---|---|
| Public title | High Flow Nasal Oxygen during Endobronchial Ultrasound to prevent low oxygen levels. |
| Scientific title | High flow humidified nasal oxygen to prevent desaturation during EBUS – a randomised controlled trial |
| Primary sponsor | Royal Melbourne Hospital |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 4 |
| Countries | Australia |
| Conditions | Endobronchial Ultrasound; Endobronchial Ultrasound;Anaesthesiology - Anaesthetics;Respiratory - Other respiratory disorders / diseases |
| Interventions | High flow humidified nasal oxygen. Oxygen administered via the Optiflow THRIVE device, at a flow rate of 50-70LPM as tolerated, humidified using the Fisher and Paykel 850 humidifier, to a humidity of 70% relative humidity. The oxygen… |
| Registration date | Aug 12, 2016 |
| Target size | 60 |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: